Bartosz Brzoszczyk

Bartosz Brzoszczyk

Auto-generated profile, based on publicly available information

Bartosz Brzoszczyk

Clinic of Urology, Jan Biziel University Hospital No. 2, Nicolaus Copernicus University in Torun, Collegium Medicum, Poland

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2019 in Neuropsychiatric Disease and Treatment
Verified
Journal Article
Open access
PDF file
PJPiotr Jarzemski
Piotr Jarzemski
BBBartosz Brzoszczyk
Bartosz Brzoszczyk
APAlicja Popiołek
Alicja Popiołek
ASAgnieszka Stachowicz-Karpińska
Agnieszka Stachowicz-Karpińska
SGSzymon Gołota
Szymon Gołota
ABAlina Borkowska
Alina Borkowska
Background: Prostate cancer (PC) is one of the most common malignant tumors in developed countries. Both PC and treatment for PC have an adverse impact on physical and mental well-being, and are associated with decreased quality of life. The aim of the present study was to examine the relationship between neuropsychological symptoms and clinical course in PC patients undergoing radical prostatectomy with or without adjunct therapy. Methods: The cohort comprised 100 patients aged 50–77 years who underwent radical, laparoscopic prostatectomy for PC. Twenty-three patients with a more advanced clinical stage also received adjuvant therapy (radiotherapy and hormonotherapy). Clinical evaluation included self-report assessment, physical examination, and biochemical tests (testosterone and prostate-specific antigen). In addition, the presence and intensity of sexual dysfunction, urinary dysfunction, anxiety-depressive symptoms, and cognitive dysfunction were assessed. Results: The group of patients undergoing complex therapy was characterized by a significantly worse result of deferred memory (p=0.04). A significant correlation was found between post-surgery erectile function and scores for the visual working memory test (correct answers; VWMT-C; p=0.006) and Hospital Anxiety and Depression Scale depression (p=0.045) and anxiety scores (p=0.02). A trend toward significance was also observed for simple reaction time (correct answers; p=0.09). A significant correlation was found between results for the delayed verbal memory test and all physical symptoms (International Consultation on Incontinence Questionnaire-total, p=0.02; International Index of Erectile Function-5, p=0.006). Similarly, a significant correlation was found between the VWMT-C and score for sexual dysfunction (p=0.003). Conclusion: Patients undergoing both surgical and adjunct therapy for PC are at risk for psychological burden and cognitive disorders. In the present cohort, physical complications of therapy were associated with depression, anxiety, and delayed memory dysfunction. Furthermore, this study has proven that fewer complications after surgery are associated with better psychological and cognitive functioning. Appropriate neuropsychological and psychiatric care can improve compliance and quality of life among patients after prostatectomy.

1 May 2022 in Cancer Management and Research
Verified
Journal Article
Open access
PDF file
APAlicja Popiolek
Alicja Popiolek
BBBartosz Brzoszczyk
Bartosz Brzoszczyk
PJPiotr Jarzemski
Piotr Jarzemski
MPMałgorzata Piskunowicz
Małgorzata Piskunowicz
MJMarcin Jarzemski
Marcin Jarzemski
MBMaciej Bieliński
Maciej Bieliński
Purpose: Prostate cancer (PC) is one of the most common malignancies in men. The population of PC survivors is growing, and understanding the roles of different factors that affect quality of life (QoL) is important. We investigated the effects of affective temperament on the QoL of PC patients. Patients and Methods: All subjects (n=100) underwent medical evaluation [including demographic data, medical history, physical examination, biochemical tests, and assessment of urinary incontinence (ICIQ-UI SF scale) and erectile dysfunction (ED) (IIEF-5 and subjective ED scale)] and psychological evaluation [including assessment of affective temperament using the TEMPS-A scale, depression and anxiety (using HADS), and QoL (EORTC-QLQ-C30 and EORTC-PR25)]. The relationships between individual variables were examined. Results: Erection quality after treatment was associated with better QoL in most parameters. Similar strong relationships were observed between the urinary incontinence scale and QoL. Depressive, cyclothymic, irritable, and anxious temperaments were associated with decreased QoL. On the EORTC-PR25 scale, associations were observed between a depressive temperament and worse sexual function and urinary symptoms, between a cyclothymic temperament and worse urinary symptoms, and between an irritable temperament and worse sexual functioning. Multivariate analysis identified the severity of anxiety and depression symptoms measured by HADS as the most important psychological factors affecting QoL. Conclusion: QoL in PC survivors depends on many factors, including age, interval since diagnosis, tumor stage, treatment, complications, and affective temperament profile. Depressive, cyclothymic, irritable, and anxious temperaments were associated with poorer QoL in selected domains, which was not observed for a hyperthymic temperament. The temperament profile of patients was associated with mood and anxiety level, which were important determinants of a poorer QoL.

1 April 2026 in Research and Reports in Urology
Verified
Journal Article
Open access
APAlicja Popiolek
Alicja Popiolek
BBBartosz Brzoszczyk
Bartosz Brzoszczyk
ENEwa Niemczuk
Ewa Niemczuk
ABAlina Borkowska
Alina Borkowska
PJPiotr Jarzemski
Piotr Jarzemski
MBMaciej Bieliński
Maciej Bieliński
To assess modifiable risk factors for prostate cancer —smoking, physical activity, and obesity—in PC survivors, and their relationship with cognitive and affective functioning. The study included 118 prostate cancer survivors. Clinical and psychological data were collected. Participants completed questionnaires on health risk behaviors. Cognitive functions were assessed using the Neurotest battery; anxiety and depression were measured via the Hospital Anxiety and Depression Scale. Statistical analyses included correlations and between-group comparisons (with post hoc tests). Smokers recalled fewer words in the Verbal Memory Test. Current smokers also performed worse on the second Verbal Memory Test trial (p=0.035) and had slower response times in the Visuospatial Memory Test (p=0.013). Obese individuals had slower Go/No-Go reaction times compared to non-obese participants (p=0.02). No other cognitive or affective differences were found. Our preliminary findings suggest that smoking may impair memory in prostate cancer survivors. The relationship between physical activity, obesity, and cognitive and affective outcomes appears more complex and warrants further investigation.

1 March 2026 in Research and Reports in Urology
Verified
Journal Article
Open access
PDF file
BBBartosz Brzoszczyk
Bartosz Brzoszczyk
APAlicja Popiołek
Alicja Popiołek
PJPiotr Jarzemski
Piotr Jarzemski
KGKinga Grzybowska
Kinga Grzybowska
WTWiktoria Tobolska
Wiktoria Tobolska
MBMaciej Bieliński
Maciej Bieliński
Introduction: Radical prostatectomy (RP) is a standard curative treatment for localized Prostate cancer (PCa), but may negatively affect health-related quality of life (HRQoL) through urinary incontinence, erectile dysfunction, psychological distress, cognitive decline. Neurovascular bundle (NVB)–sparing techniques aim to preserve functional outcomes; however, their effects on neurocognitive performance remain unclear. Purpose: This study evaluated the impact of bilateral NVB-sparing RP on cognitive function, psychological status, HRQoL, and biochemical recurrence in patients with PCa. Methods: This retrospective study included 100 Caucasian patients who underwent laparoscopic RP between 2017 and 2022, either with bilateral intrafascial NVB preservation or without NVB sparing, according to European Association of Urology criteria. All surgeries were performed by high-volume surgeons with experience exceeding 250 RPs each. Cognitive function was assessed using a standardized computer-based test. Psychological and functional status was evaluated with the HADS Scale, ICIQ-UI SF and IIEF5 scale. HRQoL was measured with the EORTC QLQ-C30 and PR25 questionnaires. Serum prostate-specific antigen (PSA) and testosterone levels were analyzed. Results: Patients undergoing NVB-sparing RP demonstrated faster reaction times and better visual working memory compared with the non–NVB-sparing group. Postoperative erectile function, urinary continence, and testosterone levels were significantly superior following NVB preservation. HRQoL outcomes favored NVB-sparing RP, including higher global health status, physical, emotional, and cognitive functioning, and reduced fatigue. Anxiety and depression scores were lower but did not reach statistical significance. Lower postoperative PSA and absence of biochemical recurrence were associated with better verbal memory and executive functioning. No significant differences in BCR rates were observed between groups. Conclusion: Bilateral NVB-sparing RP preserves urinary and sexual function while supporting cognitive performance and psychosocial well-being, resulting in improved HRQoL without increasing the risk of BCR. These findings confirm the oncological safety of NVB-sparing RP and support the inclusion of neurocognitive and quality-of-life outcomes in surgical decision-making for patients with prostate cancer.

15 November 2019 in European Urology Supplements
Verified
Journal Article
Closed access
BBB. Brzoszczyk
B. Brzoszczyk
PJPiotr Jarzemski
Piotr Jarzemski
APAlicja Popiolek
Alicja Popiolek
ASAgnieszka Stachowicz-Karpińska
Agnieszka Stachowicz-Karpińska
SGS. Gołota
S. Gołota
ABAlina Borkowska
Alina Borkowska